InCred Wealth in Hyper Growth Stage
Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase I/Ib Study of Its Novel PARP Inhibitor (RP12146) in Patients With Advanced Solid Tumors
KPIT Q2FY22 USD Revenue Grows 23.02 Percent Y-o-Y, Increases Revenue and Profit Outlook for the Year
Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website
Nathan Jones, CEO of Xlear, Inc. Statement in Response to a Lawsuit Filed by the Department of Justice, on Behalf of the United States, Alleging That Certain Statements Made by Xlear Violated the FTC Act and the Consumer Protection Act
Prof. (Dr.) Sunil Kumar, Director General of Health Services, Launches 6th Edition of the Standard Treatment Guidelines: A Manual for Medical Therapeutics, 2021